Latest
What changed, according to the authoritative record — the newsroom, the weekly briefing, the dated ledger and the decisions still to come.
Sections
IntelligenceState-change ledger across agencies, courts and legislatures.Open →Weekly briefingThe week in medicine and policy, with a permanent issue archive.Open →Decision calendarHearings, votes, comment deadlines and effective dates, nearest first.Open →Records ledgerOne dated record per verified event.Open →Event timelineThe chronology behind every dated claim on the site.Open →Now · Last 72 hoursThe front-page newsroom modules.Open →Decisions approachingWhat has not happened yet, and who decides.Open →
Newest in Latest
- KPSGILL Weekly
- The 2026 record so far: 1 January – 17 August
- A vaccine order, a population moved out of managed care, and a Board in session
- A Board adjourns, a refill rule takes effect, and inhalers ship to every school
- A federal AI docket opens, four regulators act on devices and medicines, and the consumer platforms move without a rule
- Comment closing, a Board agenda and a refill rule
- FMCSA limits non-domiciled commercial driver licences to three visa categories
- D.C. Circuit denies an emergency stay of the non-domiciled CDL rule
- Rivera Lujan v. FMCSA argued before a three-judge D.C. Circuit panel
- California court orders the DMV to let about 20,000 drivers reapply
Everything in Latest · 68 pages
Intelligence 1
Weekly briefing 10
- A Board adjourns, a refill rule takes effect, and inhalers ship to every school
- A federal AI docket opens, four regulators act on devices and medicines, and the consumer platforms move without a rule
- A tracked AI bill becomes law, the Match opens, and FDA moves on devices, drugs and a boxed warning
- A vaccine order, a population moved out of managed care, and a Board in session
- Comment closing, a Board agenda and a refill rule
- Every issue, permanently
- KPSGILL Weekly — issue of August 15, 2026
- The 2026 record so far: 1 January – 17 August
- This week on the record: a licensing rule argued, funding settled, and an outbreak count that has not moved
- What changed this week, and what it changes here
Decision calendar 1
Records ledger 55
- 2027 Main Residency Match registration opens
- AB 1199 (health care provider credentialing) completes legislative passage: Assembly concurrence 62–0
- AB 2575 completes legislative passage: Senate 21–10, Assembly concurrence 51–16
- AB 2575 passes the Senate 21–10 on the amended text and returns to the Assembly for concurrence
- Australia launches its first National Health Literacy Framework
- Australia publishes orientation resources for internationally qualified health professionals and supervisors
- California court orders the DMV to let about 20,000 drivers reapply
- California’s challenge to withheld federal highway funds argued in the D.C. Circuit
- Camizestrant (Etcamah) receives accelerated approval for ESR1-mutated breast cancer, guided by a blood test
- CDC reports 3,294 measles cases in the United States so far in 2026
- CMS announces $149.3 million for Arkansas under the Rural Health Transformation Program
- CMS announces $58 million for Hawaii under the Rural Health Transformation Program
- CMS bars 11 medical-equipment suppliers from Medicare Advantage and Part D payment over suspected fraudulent billing
- CMS-2454-IFC: Medicaid community engagement requirements, with state start by 1 January 2027
- Continuing appropriations signed, funding federal agencies through 11 December 2026
- CY 2027 Home Health PPS proposed rule: comment period closed at 5:00 PM EDT, 31 August
- D.C. Circuit denies an emergency stay of the non-domiciled CDL rule
- Documentary records
- DOJ restates the national Fraud Division’s priorities, health care among them
- Ebola in the Democratic Republic of the Congo: 7,258 confirmed cases and 3,510 deaths
- FDA adds a boxed warning to ferric carboxymaltose (Injectafer) for symptomatic low phosphate
- FDA Early Alert: Bravo CF esophageal pH-monitoring capsule delivery devices may fail to attach or detach
- FDA updates its PFAS-in-medical-devices material and adds a new FAQ
- Federal IDR Gateway opens for account creation ahead of the late-2026 move from web forms
- Final passage day: the 2025–2026 regular session’s last day for each house to pass bills
- FMCSA limits non-domiciled commercial driver licences to three visa categories
- Governor signs 13 child online-safety bills, including companion-chatbot crisis protocols (SB 1119)
- Governor signs 46 bills, including Medi-Cal coordination of benefits (AB 1126), Medi-Cal work or community engagement (AB 2161) and the health omnibus (SB 1447)
- Governor signs AB 1760 (Dental Practice Act) and AB 2503 (pupil exertional heat illness)
- Governor signs SB 813 (independent verification of AI systems) and AB 1405 (AI auditor registry)
- Governor signs wildfire-recovery package: smoke-contamination testing standards, insurer duties and mortgage forbearance
- Health Canada consults on prioritising certain generic submissions involving domestic manufacturing
- Health Canada restructures generic-drug review: prioritisation, capped extensions, targeted backlog flexibility
- Health Canada’s consultations on the Ministerial Reliance Order guidance and the domestic-manufacturing generic pilot close
- HHS announces $77 million in behavioral-health grants, including $9.4 million for suicide prevention and 988 follow-up
- HHS holds the Live Real Life symposium on children’s screen use and announces clinician continuing education
- HHS Live Real Life symposium on children’s screen use
- House committee reports H.R. 5688 on CDL English proficiency and status verification
- Isembyld (apitegromab-mstn) approved as the first SMA therapy that targets muscle loss
- NHS England 2026 flu campaign, phase one
- NHS England begins phase one of the 2026 flu vaccination campaign
- Pixclara (floretyrosine F 18) approved as a PET imaging drug for glioma
- Rivera Lujan v. FMCSA argued before a three-judge D.C. Circuit panel
- Russian health orders 434н and 540н take effect 1 September 2026
- SB 903 (AI and the practice of therapy) completes legislative passage: Senate concurrence 40–0, ordered to enrolling
- Sevabertinib (Hyrnuo) accelerated approval expanded to first-line HER2-mutant non-squamous lung cancer
- TGA adds eight ARTG entries to its list of ventilator, CPAP and BiPAP devices unaffected by foam-material concerns
- TGA ventilator, CPAP and BiPAP unaffected-device list
- UK Government tables three Health Bill amendments affecting the MHRA statutory framework
- WHO DRC Ebola response: vaccines and therapeutics in trials
- WHO Member States briefing: three vaccines and three therapeutics reported in trials in the DRC Ebola response
- WHO: Ervebo protection against Bundibugyo virus is unestablished; off-label use recommended only within research protocols
- WHO/Europe publishes the Report of the Knowledge Community on Responsible AI in Health
- WHO/Europe Report of the Knowledge Community on Responsible AI in Health
- Zanvastro (zilganersen) approved as the first disease-modifying treatment for Alexander disease